Case report: Low-dose interleukin-2: a treatment of bullous pemphigoid with predominantly perifollicular blistering caused by PD-1/PD-L1 inhibitor

Case report: Low-dose interleukin-2: a treatment of bullous pemphigoid with predominantly perifollicular blistering caused by PD-1/PD-L1 inhibitor

ObjectivesThis study aimed to evaluate the efficacy of low-dose interleukin (IL-2) treatment for bullous pemphigoid (BP) caused by anti-programmed cell death protein 1/ligand 1 (PD-1/PD-L1) inhibitors.MethodsLow-dose IL-2 treatment was standardized for BP. The Bullous Pemphigoid Disease Area Index (...

Full description

Saved in:
Bibliographic Details
Main Authors: Yingyue Zhang, Xianwei Cao, Jianbo Tong
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Immunology
Subjects:
bullous pemphigoid
Low-dose IL-2
PD-1/PD-L1 inhibitor
perifollicular blistering
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1496413/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items